Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction.
about
Sinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited ratsCardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir)Glutamine Reduces the Apoptosis of H9C2 Cells Treated with High-Glucose and Reperfusion through an Oxidation-Related Mechanism.Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet.Partial inhibition of the ubiquitin-proteasome system ameliorates cardiac dysfunction following ischemia-reperfusion in the presence of high glucoseMuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling.Glycation abolishes the cardioprotective effects of albumin during ex vivo ischemia-reperfusion.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Three pentacyclic triterpenes protect H9c2 cardiomyoblast cells against high-glucose-induced injury.3-Hydroxy-3-methylglutaric and 3-methylglutaric acids impair redox status and energy production and transfer in rat heart: relevance for the pathophysiology of cardiac dysfunction in 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency.Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.Oleanolic acid alleviated pressure overload-induced cardiac remodeling.Detrimental effects of acute hyperglycaemia on the rat heart.Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies
P2860
Q28542819-489809D1-D990-408D-AE3C-5D2177BC1934Q35009815-BDD83A20-1318-45B1-B667-511D96FF35B5Q35683182-91FAE656-60EE-42CC-A0FD-769F60092A4EQ35716907-69920136-1F1C-4B3E-A6DA-1E2E4CBCC2BEQ35896759-FFA27910-F25A-4B76-86AE-4E2D162DA714Q35920226-D4700B31-9CD6-4BB0-A8DF-924016E00A73Q36267548-C5DCAD0B-FD3E-4A85-835C-1D66BE711D07Q37609045-3DD95BDD-2C50-406A-94E5-E5282F5A25A6Q38620860-E2403832-C3E0-4AA7-AA9A-3347C112C82BQ39037113-1645192E-D7E4-41CB-87E2-56E85EB181AFQ39588663-9104E73A-12C1-4AEB-9794-53A57E69E874Q41470940-DD5B7579-7BF4-4781-9117-7B3FF56714D7Q53405909-ECF62569-F0EE-4DE4-AC3F-FC4C1FA82B3DQ54521654-08976C5F-FCAA-4ACD-819F-376AF1CB518BQ58761049-013C6F54-D64D-49A2-991D-496F24BEA758
P2860
Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@ast
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@en
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@nl
type
label
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@ast
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@en
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@nl
prefLabel
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@ast
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@en
Oleanolic acid: a novel cardio ...... duced contractile dysfunction.
@nl
P2093
P2860
P50
P1433
P1476
Oleanolic acid: a novel cardio ...... nduced contractile dysfunction
@en
P2093
Athiq Wahab
Makhosazane Zungu-Edmondson
Mohamed A Fahim
Mohamed Y Hasan
Mohammed Shafiullah
Nonkululeko Dlamini
Philippe Rondeau
Rudo F Mapanga
Uthra Rajamani
P2860
P304
P356
10.1371/JOURNAL.PONE.0047322
P407
P577
2012-10-16T00:00:00Z